Glynis Ablon, MD
Enriched profileAssociate Clinical Professor, UCLA · University of California, Los Angeles
Glynis Ablon is Associate Clinical Professor, UCLA at University of California, Los Angeles. OpenAlex indexes 86 publications with 1,697 citations (h-index 21); ClinicalTrials.gov lists 8 registered studies with this person as an investigator.
Data verified 23 Oct 2026
Overview
Updated 25 Oct 2026
Glynis Ablon, M.D., is Associate Clinical Professor, UCLA at University of California, Los Angeles. The public record shows 86 publications with 1,697 citations (h-index 21), centered on Facial Rejuvenation and Surgery Techniques, Dermatologic Treatments and Research, Botulinum Toxin and Related Neurological Disorders. It also documents an investigator role on 8 registered clinical trials, industry payments reported by 30 companies.
- Most recent indexed publication: 2026 · Journal of cosmetic dermatology
- Top research focus: Facial Rejuvenation and Surgery Techniques
- 8 registered trials on ClinicalTrials.gov
- Open Payments reporting from 30 companies
Generated from the cited public record · current as of 25 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 3 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 33.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 25 Oct 2026
Listed as an investigator on 8 registered studies on ClinicalTrials.gov. The most recent:
- Outcomes Associated With Tirbanibulin for Large Field Application on the Face in the U.S (CLEAR)
Sponsor: Avant Health LLC
Industry payments
Updated 25 Oct 2026
30 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Galderma Laboratories, L.P.Program year202550 payments$89,709openpaymentsdata.cms.gov ↗
- ABBVIE INC.Program year20255 payments
- Botanix SB IncProgram year20252 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
100%Azole Antifungal100%Jublia100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 25 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- The Safety and Efficacy of a Novel Saw Palmetto (Serenoa repens) Extract for Promoting Hair Growth in Adults With Self-Perceived Thinning Hair: 180-Day Results.
Journal of cosmetic dermatology
Clinical Trial2026 - A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of a Nutraceutical Supplement With Standardized Botanicals in Males With Thinning Hair.
Journal of cosmetic dermatology
Clinical Trial2025
Most-cited works
by citation count (OpenAlex)- 01
- 02Phase 3 Trials of Tirbanibulin Ointment for Actinic KeratosisArticle167 citations2021
- 03Lipomas treated with subcutaneous deoxycholate injectionsArticle137 citations2005
- 04Treatment of Lower Eyelid Fat Pads Using Phosphatidylcholine: Clinical Trial and ReviewArticle92 citations2004
- 05
Network
Updated 25 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 25 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by others
where others cite or feature them- Other
meetings-external.aad.org/IA2024/Speakers/Details/25035
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →meetings-external.aad.org ↗ - Other
livderm.org/glynis-r-ablon.html
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →livderm.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 25 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →livderm.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →livderm.org ↗
Editorial & leadership roles
journal and society appointments- Member
SBS Planning Committee (South Beach Symposium)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →dermatologytimes.com ↗ - Fellow
American Academy of Dermatology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →livderm.org ↗ - Member
American Society for Dermatologic Surgery
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →livderm.org ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →livderm.org ↗
Secondary affiliations
appointments beyond the home institution- Owner and director
Ablon Skin Institute and Research Center, Manhattan Beach, California
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →dermatologytimes.com ↗
Media & interviews
press, podcasts and appearances- Dermatology Times video: Glynis Ablon
MD, on getting involved in clinical trials
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →dermatologytimes.com ↗ - Dermatology Times: Glynis Ablon
MD, FAAD, talks Winter Clinical Hawaii
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →dermatologytimes.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Dennis Slamon, MD
University of California, Los Angeles
Beth Karlan, MD
University of California, Los Angeles
Richard Casaburi, MD
University of California, Los Angeles
Jerome Engel, MD
University of California, Los Angeles
Robert Modlin, MD
University of California, Los Angeles
Heidi Kong, MD
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Jon Hanifin, MD
Oregon Health & Science University (OHSU)
Victoria Werth, MD
Perelman School of Medicine at the University of Pennsylvania